Characterisation of L-Type Amino Acid Transporter 1 (LAT1) Expression in Human Skeletal Muscle by Immunofluorescent Microscopy

被引:32
|
作者
Hodson, Nathan [1 ]
Brown, Thomas [1 ]
Joanisse, Sophie [1 ]
Aguirre, Nick [2 ]
West, Daniel W. D. [3 ]
Moore, Daniel R. [3 ]
Baar, Keith [2 ]
Breen, Leigh [1 ]
Philp, Andrew [1 ]
机构
[1] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham B15 2TT, W Midlands, England
[2] Univ Calif Davis, Davis, CA 95616 USA
[3] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON M5S 1A1, Canada
来源
NUTRIENTS | 2018年 / 10卷 / 01期
基金
英国生物技术与生命科学研究理事会;
关键词
LAT1; leucine; protein; amino acid transport; BLOOD-BRAIN-BARRIER; RESISTANCE EXERCISE; ENDURANCE EXERCISE; PROTEIN-SYNTHESIS; PLASMA-MEMBRANE; GENE-EXPRESSION; IN-VIVO; GROWTH; CELLS; AVAILABILITY;
D O I
10.3390/nu10010023
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The branch chain amino acid leucine is a potent stimulator of protein synthesis in skeletal muscle. Leucine rapidly enters the cell via the L-Type Amino Acid Transporter 1 (LAT1); however, little is known regarding the localisation and distribution of this transporter in human skeletal muscle. Therefore, we applied immunofluorescence staining approaches to visualise LAT1 in wild type (WT) and LAT1 muscle-specific knockout (mKO) mice, in addition to basal human skeletal muscle samples. LAT1 positive staining was visually greater in WT muscles compared to mKO muscle. In human skeletal muscle, positive LAT1 staining was noted close to the sarcolemmal membrane (dystrophin positive staining), with a greater staining intensity for LAT1 observed in the sarcoplasmic regions of type II fibres (those not stained positively for myosin heavy-chain 1, Type II25.07 +/- 5.93, Type I13.71 +/- 1.98, p < 0.01), suggesting a greater abundance of this protein in these fibres. Finally, we observed association with LAT1 and endothelial nitric oxide synthase (eNOS), suggesting LAT1 association close to the microvasculature. This is the first study to visualise the distribution and localisation of LAT1 in human skeletal muscle. As such, this approach provides a validated experimental platform to study the role and regulation of LAT1 in human skeletal muscle in response to various physiological and pathophysiological models.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Role of L-Type Amino Acid Transporter 1 (LAT1) for the Selective Cytotoxicity of Sesamol in Human Melanoma Cells
    Srisongkram, Tarapong
    Weerapreeyakul, Natthida
    Karkkainen, Jussi
    Rautio, Jarkko
    MOLECULES, 2019, 24 (21):
  • [22] Vitamin D stimulates placental L-type amino acid transporter 1 (LAT1) in preeclampsia
    Jia, Xiaotong
    Cao, Yang
    Ye, Lingyu
    Liu, Xueqing
    Huang, Yujia
    Xiaolei, Yuan
    Lu, Chunmei
    Xu, Jie
    Zhu, Hui
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [23] Vitamin D stimulates placental L-type amino acid transporter 1 (LAT1) in preeclampsia
    Xiaotong Jia
    Yang Cao
    Lingyu Ye
    Xueqing Liu
    Yujia Huang
    Xiaolei Yuan
    Chunmei Lu
    Jie Xu
    Hui Zhu
    Scientific Reports, 12
  • [24] Positive Regulation of Decidualization by L-Type Amino Acid Transporter 1 (lat1) in Pregnant Mice
    Wang, Xiaojie
    Tan, Dongmei
    Ma, Jing
    Liang, Hao
    Zhang, Qian
    Tan, Yi
    Wang, Jiang
    Luo, Wenping
    NUTRIENTS, 2016, 8 (11)
  • [25] Molecular characteristics supporting L-Type amino acid transporter 1 (LAT1)-mediated translocation
    Karkkainen, Jussi
    Laitinen, Tuomo
    Markowicz-Piasecka, Magdalena
    Montaser, Ahmed
    Lehtonen, Marko
    Rautio, Jarkko
    Gynther, Mikko
    Poso, Antti
    Huttunen, Kristiina M.
    BIOORGANIC CHEMISTRY, 2021, 112
  • [26] High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas
    Yanagisawa, Nobuyuki
    Ichinoe, Masaaki
    Mikami, Tetuo
    Nakada, Norihiro
    Hana, Kiyomi
    Koizumi, Wasaburo
    Endou, Hitoshi
    Okayasu, Isao
    JOURNAL OF CLINICAL PATHOLOGY, 2012, 65 (11) : 1019 - 1023
  • [27] l-Type Amino Acid Transporter 1 (LAT1/Lat1)-Utilizing Prodrugs Can Improve the Delivery of Drugs into Neurons, Astrocytes and Microglia
    Johanna Huttunen
    Soile Peltokangas
    Mikko Gynther
    Teemu Natunen
    Mikko Hiltunen
    Seppo Auriola
    Marika Ruponen
    Kati-Sisko Vellonen
    Kristiina M. Huttunen
    Scientific Reports, 9
  • [28] L-Type Amino Acid Transporter 1 (LAT1/Lat1)-Utilizing Prodrugs Can Improve the Delivery of Drugs into Neurons, Astrocytes and Microglia
    Huttunen, Johanna
    Peltokangas, Soile
    Gynther, Mikko
    Natunen, Teemu
    Hiltunen, Mikko
    Auriola, Seppo
    Ruponen, Marika
    Vellonen, Kati-Sisko
    Huttunen, Kristiina M.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [29] L-Type Amino Acid Transporter 1 (LAT1) Is Frequently Expressed in Thymic Carcinomas but Is Absent in Thymomas
    Kaira, Kyoichi
    Oriuchi, Noboru
    Imai, Hisao
    Shimizu, Kimihiro
    Yanagitani, Noriko
    Sunaga, Noriaki
    Hisada, Takeshi
    Ishizuka, Tamotsu
    Kanai, Yoshikatsu
    Endou, Hitoshi
    Nakajima, Takashi
    Mori, Masatomo
    JOURNAL OF SURGICAL ONCOLOGY, 2009, 99 (07) : 433 - 438
  • [30] Downregulation of LAT1 (L-type amino acid transporter 1/SLC7A5) in human cancer.
    Oliveira, A.
    Soares-da-Silva, P.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28